Oliver Kurzai

National Reference Center for Invasive Fungal Infections · Head Fungal Septomics · Head +49 3641 532-1347 oliver.kurzai@leibniz-hki.de

Curriculum vitae

Main Research Areas

Infection biology of human pathogenic fungi (especially Candida albicans)
Infection biology of Neisseria meningitidis

Professional Career

Since 2017	Chair of Medical Microbiology and Mycology, Institute for Hygiene and Microbiology, Julius Maximilians University Würzburg and head of the research group Fungal Septomics at Leibniz Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute Jena
2009-2016	Professor (W2) for Fungal Septomics, Friedrich-Schiller-University Jena
2008	Habilitation in medical microbiology, University Würzburg
2006	Medical specialist in microbiology, virology and infection epidemiology (Bayerische Landesärztekammer)
2003	Head of a working group, Institut für Hygiene und Mikrobiologie, University Würzburg
2001-2002	Doctor in practical training (AiP), Institut für Hygiene und Mikrobiologie, University Würzburg
2002	Dr. med., “summa cum laude” University Würzburg
2001	Staatsexamen (state examination) in human medicine, University Würzburg

Awards · Appointments · Scientific Activities

Since 2014	Head of the Nationales Referenzzentrums für invasive Pilzinfektionen (NRZMyk)
Since 2013	Board member of the Integriertes Forschungs- und Behandlungszentrum “Center for Sepsis Control and Care” (CSCC) at the University Hospital Jena
Since 2012	Scientific Manager of the consortium “InfectControl 2020 – New Antiinfection Strategies – Science • Society • Economy” within the BMBF-Programme “Zwanzig 20 – Partnership for Innovation” (Head: Prof. A. Brakhage)
Since 2012	Editor-in-chief, Medical Mycology Case Reports, member (ex officio) of the executive board of the International Society for Human & Animal Mycology (ISHAM)
Since 2011	Elected note taker at the Deutschsprachige Mykologische Gesellschaft DMykG
2015-2016	Speaker of the ZIK Septomics
2011-2013	Editor, Journal of Basic Microbiology
2009	Hans-Rieth-poster prize from the Deutschsprachige Mykologische Gesellschaft (DMykG)
2008	Award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie
2003	Science award from the Unterfränkische Gedenkjahrstiftung
2003	Dissertation award from the medical faculty of the University Würzburg
2002	Becton-Dickinson PhD award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie

Publications

Aldejohann AM, Wiese-Posselt M, Gastmeier P, Kurzai O (2022) Expert recommendations for prevention and management of Candida auris transmission. Mycoses 65(6), 590-598. (Review)

Details

Belyaev I^*, Marolda A^*, Praetorius JP, Sarkar A, Medyukhina A, Hünniger K, Kurzai O, Figge MT (2022) Automated characterisation of neutrophil activation phenotypes in ex vivo human Candida blood infections. Comput Struct Biotechnol J 20, 2297-2308.

Details

Bloos F, Held J, Kluge S, Simon P, Kogelmann K, de Heer G, Kuhn SO, Jarczak D, Motsch J, Hempel G, Weiler N, Weyland A, Drüner M, Gründling M, Meybohm P, Richter D, Jaschinski U, Moerer O, Günther U, Schädler D, Weiss R, Putensen C, Castellanos I, Kurzai O, Schlattmann P, Cornely OA, Bauer M, Thomas-Rüddel D (2022) (1 → 3)-β-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial. Intensive Care Med 48(7), 865-875.

Details

Engels G, Forster J, Streng A, Rücker V, Rudolph P, Pietsch F, Wallstabe J, Wallstabe L, Krauthausen M, Schmidt J, Ludwig T, Bauer C, Gierszewski D, Bendig J, Timme S, Jans T, Weißbrich B, Romanos M, Dölken L, Heuschmann P, Härtel C, Gágyor I, Figge MT, Liese J, Kurzai O (2022) Acceptance of different self-sampling methods for semiweekly SARS-CoV-2 testing in asymptomatic children and childcare workers at German Day Care Centers: A nonrandomized controlled trial. JAMA Netw Open 5(9), e2231798.

Details

Forster J, Koc Ö, Koeppel MB, Hamprecht A, Kurzai O, Suerbaum S, Wagener J, Dichtl K (2022) β-1,3-D-glucan and galactomannan as biomarkers for the detection of invasive Geotrichum and Magnusiomyces infections: a retrospective evaluation. J Clin Microbiol 60(1), e0160721.

Details

Forster J, Streng A, Rudolph P, Rücker V, Wallstabe J, Timme S, Pietsch F, Hartmann K, Krauthausen M, Schmidt J, Ludwig T, Gierszewski D, Jans T, Engels G, Weißbrich B, Romanos M, Dölken L, Heuschmann P, Härtel C, Gágyor I, Figge MT, Kurzai O, Liese J (2022) Feasibility of SARS-CoV-2 surveillance testing among children and childcare workers at German Day Care Centers: A nonrandomized controlled trial. JAMA Netw Open 5(1), e2142057.

Details

Fuchs F, Aldejohann AM, Hoffmann AM, Walther G, Kurzai O, Hamprecht AG (2022) In vitro activity of nitroxoline in antifungal-resistant Candida species isolated from the urinary tract. Antimicrob Agents Chemother 66(6), e0226521.

Details

Gierszewski D, Kurotschka PK, Krauthausen M, Fröhlich W, Forster J, Pietsch F, Streng A, Rücker V, Wallstabe J, Hartmann K, Jans T, Engels G, Romanos M, Heuschmann P, Härtel C, Kurzai O, Liese J, Gágyor I (2022) Parents' and childcare workers' perspectives toward SARS-CoV-2 test and surveillance protocols in pre-school children day care centers: A qualitative study within the German Wü-KiTa-CoV project. Front Med (Lausanne) 9, 897726.

Details

Gierszewski D, Kurotschka PK, Krauthausen M, Fröhlich W, Forster J, Pietsch F, Streng A, Rücker V, Wallstabe J, Hartmann K, Jans T, Engels G, Romanos M, Heuschmann P, Härtel C, Kurzai O, Liese J, Gágyor I (2022) Corrigendum: Parents' and childcare workers' perspectives toward SARS-CoV-2 test and surveillance protocols in pre-school children day care centers: A qualitative study within the german Wü-KiTa-CoV project. Front Med (Lausanne) 9, 973518.

Details

Hinrichs C, Wiese-Posselt M, Graf B, Geffers C, Weikert B, Enghard P, Aldejohann A, Schrauder A, Knaust A, Eckardt KU, Gastmeier P, Kurzai O (2022) Successful control of Candida auris transmission in a German COVID-19 intensive care unit. Mycoses 65(6), 643-649.

Details